While the whole world has its eyes on the research of major pharmaceutical laboratories for a COVID vaccine, other sectors are developing and they could also help us, now and in the future, to heal.
While the whole world has its eyes on the research of major pharmaceutical laboratories for a COVID vaccine, other sectors are developing and they could also help us, now and in the future, to heal.
New technologies are everywhere: in our pockets, in our homes and cars, we find them at the office or the cinema, but we don’t always expect them in our hospitals. And yet, for the general public, all this seems like science fiction and worthy of Hollywood movies, for all the major players in the sector, this is already their daily life.
This is what Ettore Sansavini, the president of GVM Care & Research, one of the most active companies in research and new technologies applied to medicine, explains to us:
“After an initial phase of application in the industrial world, robotics and artificial intelligence are now entering healthcare. The developments in the healthcare sector are already a reality, particularly in the fields of surgical robotics and more people-centered applications.”
This sector is developing at a rapid pace, driven by the health crisis that reminded everyone of the importance of innovations in the medical sector. Indeed, just in the past few months, a French team has tested on humans a device that allows visualization of the microcirculation of blood in the brain; an American team has developed a new type of wireless and particularly miniaturized medical implant; a cardiac pump that reproduces the blood flow and pressure characteristics of a human heart has just been finalized.
Advancements in the field are multiplying, investment funds are finally interested in the sector, and companies are massively entering the stock market.
According to Sansavini, “The challenges of the coming years should focus on personalized medical care, increased use of stem cells, and nanomedicine.”
Stem cell therapy is set to become increasingly popular thanks to the reproduction of organs in the laboratory, thereby reducing the risk of rejection.
Nanomedicine, on the other hand, provides undeniable benefits in the fight against debilitating diseases often associated with aging, such as Alzheimer’s, Parkinson’s, cardiovascular diseases, cancer, or diabetes, by offering more effective remedies at a lower cost.
GVM Care&Research has always aimed to constantly push the boundaries of current technology, seeking new methods and innovative systems of clinical engineering and production process innovation accessible to everyone.
Ettore Sansavini takes a very clear-eyed view of his field of expertise “The progressive aging of the population and the decrease in the percentage of people of working age in the EU raise the issue of long-term care management.” For him, it is a certainty, the answer to these questions lies in new medical technologies that will provide a targeted and personalized response with less economic impact and will have a positive impact on the quality of life.
